Gastric bypass surgery improves psoriasis

Area of Science:

• Dermatology and Metabolic Surgery
• Investigating the interplay between autoimmune skin conditions and metabolic health.

Background:

• Psoriasis is increasingly recognized as a systemic inflammatory disease with a significant association with obesity.
• Obesity is identified as an independent risk factor for psoriasis development and severity.
• Roux-en-Y gastric bypass surgery is a bariatric procedure known for inducing substantial weight loss.

Observation:

• Two cases of patients with severe chronic psoriasis and extreme obesity (BMI > 50 kg/m²) were studied.
• Both patients underwent Roux-en-Y gastric bypass surgery, leading to significant weight reduction.
• Marked improvement in psoriasis symptoms was observed following the surgical intervention and subsequent weight loss.

Findings:

• Weight loss achieved through gastric bypass surgery correlated with a significant reduction in psoriasis severity.
• Potential shared pathophysiological mechanisms, such as chronic inflammation and elevated leptin levels, link psoriasis and obesity.
• Leptin levels, elevated in both psoriasis and obesity, decreased post-weight loss, suggesting a role in disease modulation.

Implications:

• Weight loss, particularly through bariatric surgery, may serve as an effective adjunctive therapy for obese individuals with psoriasis.
• Further research into the inflammatory pathways connecting obesity and psoriasis could reveal novel therapeutic targets.
• This study highlights the importance of addressing metabolic factors in the management of severe psoriasis.